E
WPD Pharmaceuticals Inc. WBIO
CNSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
Corporate Info
Phone Number
604 561 2687
Address
750 West Pender Street
Suite 401
Vancouver, BC V6C 2T7
Country
Canada
Year Founded
--
Details
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Employees
Business Decription
WPD Pharmaceuticals Inc., a biotechnology research and development company, engages in the research and development of medicinal products in the fields of oncology. The company develops WPD101 to treat brain cancers; WPD102 for the treatment of uveal melanoma; Berubicin to treat glioblastoma multiforme; and WP1066 for the treatment of glioblastoma and melanoma brain metastases. It also develops WP1220 for the treatment of cutaneous T-cell lymphoma; WPD103, a radiopharmaceutical based on the expression of tumor-specific receptors, such as IL-13RA2 and EphA2; and Annamycin to treat solid tumors metastasis, breast, ovarian, lung, and lower gastrointestinal tract cancers. WPD Pharmaceuticals Inc. is headquartered in Vancouver, Canada.

Weiss Ratings